South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

More than five years after the Covid-19 pandemic first ravaged the nation, many Americans are still dealing with the social ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

Today’s Forbes Daily covers Eli Lilly’s historic loss, the new GPT-5 for OpenAI’s ChatGPT, reactions to Instagram’s new map ...

The Dow Jones Industrial Average finishes down 0.5 per cent at 43,968.64. Read more at straitstimes.com. Read more at ...

A dual concern looms over American households as new tariff policies and ongoing repercussions from Social Security service ...

* U.S. President Donald Trump has the so-called 'BRIC' group of nations directly in his trade war crosshairs, slapping ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its ...

US stocks trimmed losses on Thursday, finishing mixed after President Trump's sweeping tariffs hit dozens of US trade ...

This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...